Globe Life (NYSE:GL) Issues Earnings Results

Globe Life (NYSE:GL) announced its quarterly earnings results on Wednesday. The company reported $3.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02, Zacks reports. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. Globe Life updated its FY 2025 guidance to 13.450-14.050 EPS.

Globe Life Stock Performance

NYSE GL traded down $1.23 on Thursday, reaching $121.84. The stock had a trading volume of 176,167 shares, compared to its average volume of 535,732. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. The firm has a fifty day moving average of $112.78 and a two-hundred day moving average of $106.53. Globe Life has a 1-year low of $38.95 and a 1-year high of $132.00. The company has a market cap of $10.23 billion, a P/E ratio of 10.29 and a beta of 0.81.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Monday, January 6th were issued a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date was Monday, January 6th. Globe Life’s dividend payout ratio is 8.12%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on GL shares. Wells Fargo & Company raised their target price on shares of Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Piper Sandler raised their target price on shares of Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a report on Friday, October 25th. Jefferies Financial Group boosted their target price on shares of Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a research note on Tuesday, December 10th. Evercore ISI upgraded shares of Globe Life from an “in-line” rating to an “outperform” rating and boosted their price target for the stock from $132.00 to $143.00 in a research report on Wednesday, January 8th. Finally, Raymond James boosted their target price on shares of Globe Life from $160.00 to $188.00 and gave the company a “strong-buy” rating in a report on Tuesday, October 15th. Five investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $132.18.

Insider Activity at Globe Life

In related news, CEO Frank M. Svoboda sold 13,448 shares of the business’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $112.56, for a total value of $1,513,706.88. Following the transaction, the chief executive officer now owns 18,948 shares in the company, valued at $2,132,786.88. The trade was a 41.51 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Mark A. Blinn sold 3,000 shares of the company’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total transaction of $339,690.00. Following the transaction, the director now owns 5,122 shares in the company, valued at $579,964.06. This represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 39,788 shares of company stock valued at $4,429,779 over the last quarter. 1.51% of the stock is owned by corporate insiders.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.